HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 35 filers reported holding HORIZON PHARMA INVT LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 136,032,000 | $150,514,000 | 5.41% |
| SYMPHONY ASSET MANAGEMENT LLC | 16,000,000 | $17,780,000 | 3.72% |
| CSS LLC/IL | 12,427,000 | $13,791,000 | 0.79% |
| SSI INVESTMENT MANAGEMENT LLC | 8,793,000 | $9,740,000 | 0.72% |
| Worth Venture Partners, LLC | 1,103,000 | $1,227,000 | 0.68% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,900,000 | $33,208,000 | 0.64% |
| Sonora Investment Management, LLC | 4,840,000 | $5,374,000 | 0.60% |
| Empyrean Capital Partners, LP | 8,000,000 | $8,875,000 | 0.40% |
| DLD Asset Management, LP | 5,500,000 | $6,129,000 | 0.26% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 12,500 | $10,496,000 | 0.25% |